These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 17933432)
1. Urotensin II and atherosclerosis. Loirand G; Rolli-Derkinderen M; Pacaud P Peptides; 2008 May; 29(5):778-82. PubMed ID: 17933432 [TBL] [Abstract][Full Text] [Related]
2. Human urotensin II as a link between hypertension and coronary artery disease. Watanabe T; Kanome T; Miyazaki A; Katagiri T Hypertens Res; 2006 Jun; 29(6):375-87. PubMed ID: 16940699 [TBL] [Abstract][Full Text] [Related]
4. Expression of urotensin-II in human coronary atherosclerosis. Hassan GS; Douglas SA; Ohlstein EH; Giaid A Peptides; 2005 Dec; 26(12):2464-72. PubMed ID: 16026900 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function. Maguire JJ; Kuc RE; Kleinz MJ; Davenport AP Peptides; 2008 May; 29(5):735-42. PubMed ID: 17905478 [TBL] [Abstract][Full Text] [Related]
6. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype. Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1. Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745 [TBL] [Abstract][Full Text] [Related]
8. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619 [TBL] [Abstract][Full Text] [Related]
9. Elevated expression of urotensin II and its receptor in great artery of type 2 diabetes and its significance. Xie N; Liu L Biomed Pharmacother; 2009 Dec; 63(10):734-41. PubMed ID: 19906507 [TBL] [Abstract][Full Text] [Related]
10. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet. Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831 [TBL] [Abstract][Full Text] [Related]
11. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro. Spinazzi R; Albertin G; Nico B; Guidolin D; Di Liddo R; Rossi GP; Ribatti D; Nussdorfer GG Int J Mol Med; 2006 Dec; 18(6):1107-12. PubMed ID: 17089015 [TBL] [Abstract][Full Text] [Related]
12. Effects of exogenous urotensin II on vascular remodelling after balloon injury. Zhang LF; Ding WH; Shi LB; Li K; Haom YJ; Ke YN; Tang ZS Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):477-81. PubMed ID: 19930425 [TBL] [Abstract][Full Text] [Related]
13. A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker. Rakowski E; Hassan GS; Dhanak D; Ohlstein EH; Douglas SA; Giaid A J Mol Cell Cardiol; 2005 Nov; 39(5):785-91. PubMed ID: 16171813 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure. Mori N; Hirose T; Nakayama T; Ito O; Kanazawa M; Imai Y; Kohzuki M; Takahashi K; Totsune K Peptides; 2009 Feb; 30(2):400-8. PubMed ID: 18955095 [TBL] [Abstract][Full Text] [Related]
15. Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout. Wang ZJ; Shi LB; Xiong ZW; Zhang LF; Meng L; Bu DF; Tang CS; Ding WH Peptides; 2006 Apr; 27(4):858-63. PubMed ID: 16325305 [TBL] [Abstract][Full Text] [Related]
16. [A vasoactive peptide: urotensin II]. Liu GQ; Zeng ZP Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):525-8. PubMed ID: 16178453 [TBL] [Abstract][Full Text] [Related]
17. Role of urotensin II in atherosclerotic cardiovascular diseases. Pakala R Cardiovasc Revasc Med; 2008; 9(3):166-78. PubMed ID: 18606380 [TBL] [Abstract][Full Text] [Related]
18. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide. Watanabe T; Takahashi K; Kanome T; Hongo S; Miyazaki A; Koba S; Katagiri T; Pakara R; Benedict CR Hypertens Res; 2006 Oct; 29(10):821-31. PubMed ID: 17283870 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. Langham RG; Kelly DJ; Gow RM; Zhang Y; Dowling JK; Thomson NM; Gilbert RE Am J Kidney Dis; 2004 Nov; 44(5):826-31. PubMed ID: 15492948 [TBL] [Abstract][Full Text] [Related]
20. Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy. Dai HY; Guo XG; Ge ZM; Li ZH; Yu XJ; Tang MX; Zhang Y J Diabetes Complications; 2008; 22(2):137-43. PubMed ID: 18280445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]